Retrospective Analysis Comparing Lung-RADS v2022 and British Thoracic Society Guidelines for Differentiating Lung Metastases from Primary Lung Cancer
- 1Department I, Discipline of Anatomy and Embriology, Victor Babes University of Medicine and Pharmacy, Eftimie Murgu Square 2, 300041 Timisoara, Romania.
- 2Department of Surgery, Victor Babes University of Medicine and Pharmacy, 300041 Timisoara, Romania.
- 3Doctoral School, Victor Babes University of Medicine and Pharmacy, 300041 Timisoara, Romania.
- 4Department of Infectious Disease, Victor Babes University of Medicine and Pharmacy, 300041 Timisoara, Romania.
- 5Center for Research and Innovation in Precision Medicine of Respiratory Diseases, Victor Babes University of Medicine and Pharmacy, 300041 Timisoara, Romania.
- 6Department of Physiology, Faculty of Medicine, "Vasile Goldis" Western University of Arad, 310025 Arad, Romania.
- 0Department I, Discipline of Anatomy and Embriology, Victor Babes University of Medicine and Pharmacy, Eftimie Murgu Square 2, 300041 Timisoara, Romania.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.The Lung Imaging Reporting and Data System (Lung-RADS) Version 2022 shows higher accuracy in distinguishing lung metastases from primary lung cancer on CT scans compared to British Thoracic Society guidelines. This improves diagnostic precision for patients without a prior cancer diagnosis.
Area Of Science
- Radiology
- Oncology
- Pulmonary Medicine
Background
- Differentiating lung metastases from primary lung cancer in patients without a prior cancer diagnosis is clinically significant.
- Computed tomography (CT) scans are crucial for detecting pulmonary nodules, but distinguishing their origin can be challenging.
- Existing guidelines, such as the Lung Imaging Reporting and Data System (Lung-RADS) and British Thoracic Society (BTS) guidelines, offer frameworks for nodule assessment.
Purpose Of The Study
- To compare the diagnostic performance of Lung-RADS Version 2022 and BTS guidelines in distinguishing lung metastases from de novo primary lung cancer.
- To evaluate the sensitivity and specificity of each guideline in a cohort of patients with newly detected pulmonary nodules and no prior cancer history.
Main Methods
- Retrospective analysis of 196 patients with pulmonary nodules on CT scans (2015-2022) and no prior cancer diagnosis.
- Nodules were characterized by size, number, location, margins, attenuation, and growth patterns.
- Classification of nodules using Lung-RADS Version 2022 and BTS guidelines, followed by statistical comparison of sensitivity and specificity.
Main Results
- Lung-RADS Version 2022 demonstrated significantly higher specificity (87.2%) compared to BTS guidelines (72.3%) (p < 0.001) in differentiating metastases from primary lung cancer.
- Sensitivity was comparable between Lung-RADS (91.7%) and BTS (93.8%) (p = 0.68).
- Lung metastases were associated with multiple nodules, lower lobe distribution, and smooth margins, while primary lung cancers often presented as solitary nodules in the upper lobe with spiculated margins.
Conclusions
- Lung-RADS Version 2022 offers superior specificity over BTS guidelines for differentiating lung metastases from primary lung cancer in CT scans of cancer-naive patients.
- Characteristic imaging features of nodules can aid in accurate diagnosis and guide subsequent patient management.
- The findings support the utility of Lung-RADS Version 2022 in improving diagnostic accuracy for indeterminate pulmonary nodules.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.

